FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Per Svenningsson

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Phenomena

Phosphorylation

Procedures

In Situ Hybridization

Co-author Network

Publications

TOP 3
Carly Kiselycznyk; Andrew Holmes; Richard Huganir; Xiaoqun Zhang; Per Svenningsson
Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.
Ebba Gregorsson Lundius; Nikolas Stroth; Lars Terenius; Vladana Vukojevic; Per Svenningsson
Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line.
Dag Aarsland; Per Svenningsson
Using biomarkers to disentangle different causes of Parkinsonism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Per Svenningsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carly Kiselycznyk; Andrew Holmes; Richard Huganir; Xiaoqun Zhang; Per Svenningsson
Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(4):919-24.
2013: Ebba Gregorsson Lundius; Nikolas Stroth; Lars Terenius; Vladana Vukojevic; Per Svenningsson
Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line.
Journal of neurochemistry 2013;124(3):410-7.
2013: Dag Aarsland; Per Svenningsson
Using biomarkers to disentangle different causes of Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2013;84(2):119.
2012: Martin Egeland; Mark J Millan; Elisabeth Mocaer; Xiaoqun Zhang; Per Svenningsson
Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice.
Journal of neurochemistry 2012;123(5):811-23.
2012: Therese M Eriksson; Torben Hager; Sarah Holst; Sven Ove Ogren; Benita Sjögren; Tiberiu L Stan; Per Svenningsson; Oliver Stiedl
5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
Neuropharmacology 2012;63(6):1150-60.
2012: Mohammadreza Shariatgorji; Per Svenningsson; Andras Szabo; Zoltan Banka; Richard J A Goodwin; Tibor Hasko; Laszlo Kladni; Anna Nilsson; Nicoletta Schintu; Per E Andren
Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules.
Analytical chemistry 2012;84(16):7152-7.
2012: Philippe A Melas; Hongshi Qi; Maria Rogdaki; Per Svenningsson; Gregers Wegener; Martin Werme; Anna Witasp; K Björk; Andreas Lennartsson; Aleksander A Mathé; Catharina Lavebratt
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(5):669-79.
2012: Mohammadreza Shariatgorji; Per Svenningsson; Richard J A Goodwin; Lena Gustavsson; Patrik Källback; Nicoletta Schintu; Per E Andren
Controlled-pH tissue cleanup protocol for signal enhancement of small molecule drugs analyzed by MALDI-MS imaging.
Analytical chemistry 2012;84(10):4603-7.
2012: Anna Nilsson; Hongshi Qi; Karl Skold; Nikolas Stroth; Per E Andrén; Maria Fälth; Daniel Hoyer; Xiaoqun Zhang; Per Svenningsson
Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects.
Neuropharmacology 2012;62(1):347-57.
2011: Xiaoqun Zhang; Martin Egeland; Per Svenningsson
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
Psychopharmacology 2011;218(4):621-34.
2011: Martin Egeland; Paul Greengard; Jennifer Schmidt; Per Svenningsson
Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum.
Neuropharmacology 2011;61(3):442-50.
2011: Alexandra Madeira; Anna Nilsson; Benita Sjögren; Per E Andrén; Elisabet Vikeved; Per Svenningsson
Identification of protein-protein interactions by surface plasmon resonance followed by mass spectrometry.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2011;Chapter 19():Unit19.21.
2011: Alexandra Madeira; Anna Nilsson; Elisabet Vikeved; Junfeng Yang; Xiaoqun Zhang; Per E Andrén; Per Svenningsson
Caveolin-1 interacts with alpha-synuclein and mediates toxic actions of cellular alpha-synuclein overexpression.
Neurochemistry international 2011;59(2):280-9.
2011: X Zhang; Per E Andren; Richard A Glennon; Per Svenningsson
Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism.
The Journal of comparative neurology 2011;519(9):1816-27.
2011: Mikael Skorpil; Tyler Rolheiser; Harold Robertson; Anders Sundin; Per Svenningsson
Diffusion tensor fiber tractography of the olfactory tract.
Magnetic resonance imaging 2011;29(2):289-92.
2011: K Björk; Per Svenningsson
Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents.
Annual review of pharmacology and toxicology 2011;51():211-42.
2010: Jennifer Schmidt; Emily Y Chen; Xiaoqun Zhang; John J Marshall; Alexei Morozov; Per Svenningsson; Paul Greengard
A role for p11 in the antidepressant action of brain-derived neurotrophic factor.
Biological psychiatry 2010;68(6):528-35.
2010: Martin Egeland; Jennifer Schmidt; Paul Greengard; Per Svenningsson
Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice.
Biological psychiatry 2010;67(11):1048-56.
2010: K Björk; Benita Sjögren; Per Svenningsson
Regulation of serotonin receptor function in the nervous system by lipid rafts and adaptor proteins.
Experimental cell research 2010;316(8):1351-6.
2010: Sven Pålhagen; Hongshi Qi; Björn Mårtensson; Jan Wålinder; Ann-Kathrine Granérus; Per Svenningsson
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.
Journal of neurology 2010;257(4):524-32.
2009: Anna Nilsson; Maria Fälth; Xiaoqun Zhang; Kim Kultima; Karl Skold; Per Svenningsson; Per E Andrén
Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease.
Molecular & cellular proteomics : MCP 2009;8(5):1094-104.
2009: Anna M S Kindlundh-Högberg; Xiaoqun Zhang; Per Svenningsson
S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):201-15.
2009: Jennifer Schmidt; Marc Flajolet; Abigail Maller; Emily Y Chen; Hongshi Qi; Per Svenningsson; Paul Greengard
Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(6):1937-46.
2009: Marcus Svensson; Mats Boren; Karl Skold; Maria Fälth; Benita Sjögren; Malin Andersson; Per Svenningsson; Per E Andren
Heat stabilization of the tissue proteome: a new technology for improved proteomics.
Journal of proteome research 2009;8(2):974-81.
2009: Alexandra Madeira; Elisabet Ohman; Anna Nilsson; Benita Sjögren; Per E Andrén; Per Svenningsson
Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions.
Nature protocols 2009;4(7):1023-37.
2009: Hongshi Qi; François Mailliet; Michael Spedding; Cyril Rocher; X Zhang; Philippe Delagrange; Bruce McEwen; Thérèse M Jay; Per Svenningsson
Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation.
Neuropharmacology 2009;56(1):37-46.
2008: Sven Ove Ogren; Therese M Eriksson; Elin Elvander-Tottie; Claudio D'Addario; Joanna C Ekström; Per Svenningsson; Björn Meister; Julia Kehr; Oliver Stiedl
The role of 5-HT(1A) receptors in learning and memory.
Behavioural brain research 2008;195(1):54-77.
2008: Elisabet Ohman; Anna Nilsson; Alexandra Madeira; Benita Sjögren; Per E Andrén; Per Svenningsson
Use of surface plasmon resonance coupled with mass spectrometry reveals an interaction between the voltage-gated sodium channel type X alpha-subunit and caveolin-1.
Journal of proteome research 2008;7(12):5333-8.
2008: Therese M Eriksson; Armita Golkar; Joanna C Ekström; Per Svenningsson; Sven Ove Ogren
5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice.
European journal of pharmacology 2008;596(1-3):107-10.
2008: Benita Sjögren; Linda Csöregh; Per Svenningsson
Cholesterol reduction attenuates 5-HT1A receptor-mediated signaling in human primary neuronal cultures.
Naunyn-Schmiedeberg's archives of pharmacology 2008;378(4):441-6.
2008: Helen Bateup; Per Svenningsson; Mahomi Kuroiwa; Shiaoching Gong; Akinori Nishi; Nathaniel Heintz; Paul Greengard
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.
Nature neuroscience 2008;11(8):932-9.
2008: François Mailliet; Hongshi Qi; Cyril Rocher; Michael Spedding; Per Svenningsson; Thérèse M Jay
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling.
Experimental neurology 2008;211(2):593-6.
2008: X Zhang; Per E Andren; Karima Chergui; Per Svenningsson
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
Neuropharmacology 2008;54(7):1143-52.
2008: Therese M Eriksson; Nather Madjid; Elin Elvander-Tottie; Oliver Stiedl; Per Svenningsson; Sven Ove Ogren
Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
Neuropharmacology 2008;54(7):1041-50.
2008: Xiaoqun Zhang; Per E Andren; Paul Greengard; Per Svenningsson
Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(6):2163-8.
2008: Mark J Millan; Per Svenningsson; Charles R Ashby; Michael Hill; Martin Egeland; Anne Dekeyne; Mauricette Brocco; Benjamin Di Cara; Françoise Lejeune; Nitza Thomasson; Carmen Munoz; Elisabeth Mocaër; Alan R Crossman; Laetitia Cistarelli; Sylvie Girardon; Loretta Iob; Sylvie Veiga; Alain Gobert
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
The Journal of pharmacology and experimental therapeutics 2008;324(2):600-11.
2008: Daniel G Smith; Hongshi Qi; Per Svenningsson; Mark Wade; Richard J Davis; Donald R Gehlert; George Nomikos
Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Synapse (New York, N.Y.) 2008;62(2):128-36.
2007: Per Svenningsson; Helen Bateup; Hongshi Qi; Kogo Takamiya; Richard Huganir; Michael Spedding; Bryan L Roth; Bruce S McEwen; Paul Greengard
Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine.
The European journal of neuroscience 2007;26(12):3509-17.
2007: Karl Skold; Marcus Svensson; Mathias Norrman; Benita Sjögren; Per Svenningsson; Per E Andrén
The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators.
Proteomics 2007;7(24):4445-56.
2007: Anna M S Kindlundh-Högberg; Helgi B Schiöth; Per Svenningsson
Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
Neurotoxicology 2007;28(6):1158-69.
2007: Benita Sjögren; Per Svenningsson
Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors.
FEBS letters 2007;581(26):5115-21.
2007: Anna Nilsson; Karl Skold; Benita Sjögren; Marcus Svensson; Johan Pierson; Xiaoqun Zhang; Richard M Caprioli; Jos Buijs; Björn Persson; Per Svenningsson; Per E Andrén
Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.
Journal of proteome research 2007;6(10):3952-61.
2007: Xiaoqun Zhang; Per E Andren; Per Svenningsson
Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
Physiology & behavior 2007;92(1-2):29-33.
2007: Anders Kaplan; Malin Söderström; David Fenyö; Anna Nilsson; Maria Fälth; Karl Skold; Marcus Svensson; Harald Pettersen; Staffan Lindqvist; Per Svenningsson; Per E Andrén; Lennart Björkesten
An automated method for scanning LC-MS data sets for significant peptides and proteins, including quantitative profiling and interactive confirmation.
Journal of proteome research 2007;6(7):2888-95.
2007: Paul Witkovsky; Per Svenningsson; Lily Yan; Helen Bateup; Rae Silver
Cellular localization and function of DARPP-32 in the rodent retina.
The European journal of neuroscience 2007;25(11):3233-42.
2007: Marcus Svensson; Karl Skold; Anna Nilsson; Maria Fälth; Per Svenningsson; Per E Andrén
Neuropeptidomics: expanding proteomics downwards.
Biochemical Society transactions 2007;35(Pt 3):588-93.
2007: Per Svenningsson; Eleni T Tzavara; Hongshi Qi; Robert Carruthers; Jeffrey M Witkin; George Nomikos; Paul Greengard
Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(15):4201-9.
2007: Yves Agid; György Buzsáki; David M Diamond; Richard S J Frackowiak; Jay Giedd; Jean-Antoine Girault; Anthony Grace; Jeremy J Lambert; Husseini K Manji; Helen S Mayberg; Maurizio Popoli; Alain Prochiantz; Gal Richter-Levin; Peter Somogyi; Michael Spedding; Per Svenningsson; Daniel Weinberger
How can drug discovery for psychiatric disorders be improved?
Nature reviews. Drug discovery 2007;6(3):189-201.
2007: Per Svenningsson; Paul Greengard
p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions.
Current opinion in pharmacology 2007;7(1):27-32.
2007: Marcus Svensson; Karl Skold; Anna Nilsson; Maria Fälth; Katarina Nydahl; Per Svenningsson; Per E Andrén
Neuropeptidomics: MS applied to the discovery of novel peptides from the brain.
Analytical chemistry 2007;79(1):15-6, 18-21.
2006: Benita Sjögren; Mark W Hamblin; Per Svenningsson
Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors.
European journal of pharmacology 2006;552(1-3):1-10.
2006: Lily Yan; Jessica M Bobula; Per Svenningsson; Paul Greengard; Rae Silver
DARPP-32 involvement in the photic pathway of the circadian system.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(37):9434-8.
2006: Anna M S Kindlundh-Högberg; Per Svenningsson; Helgi B Schiöth
Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
Neuropharmacology 2006;51(4):838-47.
2006: Patrick B Allen; Venetia Zachariou; Per Svenningsson; A C Lepore; D Centonze; C Costa; S Rossi; G Bender; G Chen; J Feng; G L Snyder; Giorgio Bernardi; Eric J Nestler; Z Yan; Peter A Calabresi; Paul Greengard
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.
Neuroscience 2006;140(3):897-911.
2006: Xiaoqun Zhang; Per E Andren; Per Svenningsson
Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease.
Brain research 2006;1095(1):207-10.
2006: Yong Zhang; Per Svenningsson; Roberto Picetti; Stefan D Schlussman; Angus Nairn; Ann Ho; Paul Greengard; Mary Jeanne Kreek
Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(10):2645-51.
2006: Venetia Zachariou; Véronique Sgambato-Faure; Teresa Sasaki; Per Svenningsson; Olivier Berton; Allen Fienberg; Angus Nairn; Paul Greengard; Eric J Nestler
Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):555-62.
2006: Karl Skold; Marcus Svensson; Anna Nilsson; Xiaoqun Zhang; Katarina Nydahl; Richard M Caprioli; Per Svenningsson; Per E Andrén
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.
Journal of proteome research 2006;5(2):262-9.
2006: Per Svenningsson; Karima Chergui; Ilan Rachleff; Marc Flajolet; Xiaoqun Zhang; Malika El Yacoubi; Jean-Marie Vaugeois; George Nomikos; Paul Greengard
Alterations in 5-HT1B receptor function by p11 in depression-like states.
Science (New York, N.Y.) 2006;311(5757):77-80.
2005: Mikael Andersson; Alessandro Usiello; Anders Borgkvist; Laura Pozzi; Cecilia Dominguez; Allen Fienberg; Per Svenningsson; Bertil B. Fredholm; Emiliana Borrelli; Paul Greengard; Gilberto Fisone
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(37):8432-8.
2005: Karima Chergui; Per Svenningsson; Paul Greengard
Physiological role for casein kinase 1 in glutamatergic synaptic transmission.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(28):6601-9.
2005: Xiaozhou P Ryan; Jacqueline Alldritt; Per Svenningsson; Patrick B Allen; Gang-Yi Wu; Angus Nairn; Paul Greengard
The Rho-specific GEF Lfc interacts with neurabin and spinophilin to regulate dendritic spine morphology.
Neuron 2005;47(1):85-100.
2005: Johan Pierson; Per Svenningsson; Richard M Caprioli; Per E Andren
Increased levels of ubiquitin in the 6-OHDA-lesioned striatum of rats.
Journal of proteome research 2005;4(2):223-6.
2005: Emmanuel Valjent; Vincent Pascoli; Per Svenningsson; Surojit Paul; hervé enslen; Jean-Christophe Corvol; Alexandre Stipanovich; Jocelyne Caboche; Paul J Lombroso; Angus Nairn; Paul Greengard; Denis Hervé; Jean-Antoine Girault
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(2):491-6.
2005: Per Svenningsson; Angus Nairn; Paul Greengard
DARPP-32 mediates the actions of multiple drugs of abuse.
The AAPS journal 2005;7(2):E353-60.
2005: Bertil B. Fredholm; Jiang-Fan Chen; Rodrigo A Cunha; Per Svenningsson; Jean-Marie Vaugeois
Adenosine and brain function.
International review of neurobiology 2005;63():191-270.
2004: Patrick B Allen; Audrey T Greenfield; Per Svenningsson; Derek C Haspeslagh; Paul Greengard
Phactrs 1-4: A family of protein phosphatase 1 and actin regulatory proteins.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(18):7187-92.
2004: Johan Pierson; Jeremy L Norris; Hans Aerni; Per Svenningsson; Richard M Caprioli; Per E Andrén
Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry.
Journal of proteome research 2004;3(2):289-95.
2004: Karima Chergui; Per Svenningsson; Paul Greengard
Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):2191-6.
2004: Angus Nairn; Per Svenningsson; Akinori Nishi; Gilberto Fisone; Jean-Antoine Girault; Paul Greengard
The role of DARPP-32 in the actions of drugs of abuse.
Neuropharmacology 2004;47 Suppl 1():14-23.
2004: Per Svenningsson; Akinori Nishi; Gilberto Fisone; Jean-Antoine Girault; Angus Nairn; Paul Greengard
DARPP-32: an integrator of neurotransmission.
Annual review of pharmacology and toxicology 2004;44():269-96.
2003: Per Svenningsson; Bertil B. Fredholm
Exciting news about A2A receptors.
Neurology 2003;61(11 Suppl 6):S10-1.
2003: Bertil B. Fredholm; Per Svenningsson
Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.
Neurology 2003;61(11 Suppl 6):S5-9.
2003: Ryuichi Fukui; Per Svenningsson; Toyojiro Matsuishi; Hideho Higashi; Angus Nairn; Paul Greengard; Akinori Nishi
Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice.
Journal of neurochemistry 2003;87(6):1391-401.
2003: Per Svenningsson; Eleni T Tzavara; Robert Carruthers; Ilan Rachleff; Sigrid Wattler; Michael Nehls; David L McKinzie; Allen Fienberg; George Nomikos; Paul Greengard
Diverse psychotomimetics act through a common signaling pathway.
Science (New York, N.Y.) 2003;302(5649):1412-5.
2003: Marcus Svensson; Karl Skold; Per Svenningsson; Per E Andren
Peptidomics-based discovery of novel neuropeptides.
Journal of proteome research 2003;2(2):213-9.
2003: Bertil B. Fredholm; Rodrigo A Cunha; Per Svenningsson
Pharmacology of adenosine A2A receptors and therapeutic applications.
Current topics in medicinal chemistry 2003;3(4):413-26.
2002: Per Svenningsson; Joris Arts; Lars Gunne; Per E Andren
Acute and repeated treatment with L-DOPA increase c-jun expression in the 6-hydroxydopamine-lesioned forebrain of rats and common marmosets.
Brain research 2002;955(1-2):8-15.
2002: Rebecka Klintenberg; Per Svenningsson; Lars Gunne; Per E Andrén
Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(10):1295-307.
2002: Maria Lindskog; Per Svenningsson; Laura Pozzi; Yong Kim; Allen Fienberg; James A Bibb; Bertil B. Fredholm; Angus Nairn; Paul Greengard; Gilberto Fisone
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
Nature 2002;418(6899):774-8.
2002: Per Svenningsson; Eleni T Tzavara; Feng Liu; Allen Fienberg; George Nomikos; Paul Greengard
DARPP-32 mediates serotonergic neurotransmission in the forebrain.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3188-93.
2002: Per Svenningsson; Eleni T Tzavara; Jeffrey M Witkin; Allen Fienberg; George Nomikos; Paul Greengard
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3182-7.
2002: Per Svenningsson; Catherine Le Moine
Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: possible involvement of local D5 receptors.
The European journal of neuroscience 2002;15(1):133-42.
2001: James A Bibb; Jiayun Chen; J R Taylor; Per Svenningsson; Akinori Nishi; Gretchen L Snyder; Zhen Yan; Z K Sagawa; Charles C Ouimet; Angus Nairn; Eric J Nestler; Paul Greengard
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.
Nature 2001;410(6826):376-80.
2000: Paolo Calabresi; Paolo Gubellini; Diego Centonze; Barbara Picconi; Giorgio Bernardi; Karima Chergui; Per Svenningsson; Allen Fienberg; Paul Greengard
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(22):8443-51.
2000: Björn Kull; Per Svenningsson; Bertil B. Fredholm
Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum.
Molecular pharmacology 2000;58(4):771-7.
2000: Björn Kull; Per Svenningsson; H Hall; Bertil B. Fredholm
GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain.
Neuropharmacology 2000;39(12):2374-80.
2000: Per Svenningsson; Allen Fienberg; Patrick B Allen; C L Moine; Maria Lindskog; Gilberto Fisone; Paul Greengard; Bertil B. Fredholm
Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32.
Journal of neurochemistry 2000;75(1):248-57.
2000: James A Bibb; Zhen Yan; Per Svenningsson; Gretchen L Snyder; Vincent A Pieribone; A Horiuchi; Angus Nairn; A Messer; Paul Greengard
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(12):6809-14.
2000: Per Svenningsson; Maria Lindskog; C Ledent; M Parmentier; Paul Greengard; Bertil B. Fredholm; Gilberto Fisone
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1856-60.
2000: Per Svenningsson; Lars Gunne; Per E Andren
L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
Neuroscience 2000;99(3):457-68.
2000: Per Svenningsson; Bertil B. Fredholm; Bertrand Bloch; Catherine Le Moine
Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons.
Neuroscience 2000;98(4):749-57.
1999: Per Svenningsson; Catherine Le Moine; Gilberto Fisone; Bertil B. Fredholm
Distribution, biochemistry and function of striatal adenosine A2A receptors.
Progress in neurobiology 1999;59(4):355-96.
1999: Björn Kull; S Ferré; Giulia Arslan; Per Svenningsson; Kjell Fuxe; C Owman; Bertil B. Fredholm
Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors.
Biochemical pharmacology 1999;58(6):1035-45.
1999: Maria Lindskog; Per Svenningsson; Bertil B. Fredholm; Paul Greengard; Gilberto Fisone
Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons.
The European journal of neuroscience 1999;11(6):2182-6.
1999: Per Svenningsson; L Fourreau; Bertrand Bloch; Bertil B. Fredholm; François Gonon; Catherine Le Moine
Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
Neuroscience 1999;89(3):827-37.
1999: Maria Lindskog; Per Svenningsson; Bertil B. Fredholm; Paul Greengard; Gilberto Fisone
Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
Neuroscience 1999;88(4):1005-8.
1998: Per Svenningsson; Catherine Le Moine; Incarnation Aubert; P Burbaud; Bertil B. Fredholm; Bertrand Bloch
Cellular distribution of adenosine A2A receptor mRNA in the primate striatum.
The Journal of comparative neurology 1998;399(2):229-40.
1998: Per Svenningsson; Maria Lindskog; F Rognoni; Bertil B. Fredholm; Paul Greengard; Gilberto Fisone
Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
Neuroscience 1998;84(1):223-8.
1998: Per Svenningsson; R Nergårdh; Bertil B. Fredholm
Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat.
Neuropharmacology 1998;37(3):331-7.
1997: Per Svenningsson; Håkan Hall; G Sedvall; Bertil B. Fredholm
Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study.
Synapse (New York, N.Y.) 1997;27(4):322-35.
1997: Karima Chergui; Per Svenningsson; George Nomikos; François Gonon; Bertil B. Fredholm; T H Svennson
Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.
The European journal of neuroscience 1997;9(11):2370-82.
1997: Catherine Le Moine; Per Svenningsson; Bertil B. Fredholm; Bertrand Bloch
Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(20):8038-48.
1997: Per Svenningsson; J Georgieva; E Kontny; Markus Heilig; Bertil B. Fredholm
Involvement of a c-fos-dependent mechanism in caffeine-induced expression of the preprotachykinin A and neurotensin/neuromedin N genes in rat striatum.
The European journal of neuroscience 1997;9(10):2135-41.
1997: Per Svenningsson; Catherine Le Moine; Björn Kull; Roger K Sunahara; Bertrand Bloch; Bertil B. Fredholm
Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas.
Neuroscience 1997;80(4):1171-85.
1997: Per Svenningsson; Bertil B. Fredholm
Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus.
Neuropharmacology 1997;36(9):1309-17.
1997: Per Svenningsson; George Nomikos; Ennio Ongini; Bertil B. Fredholm
Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens.
Neuroscience 1997;79(3):753-64.
1997: Per Svenningsson; Bertil B. Fredholm
Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1997;280(2):1094-101.
1996: Per Svenningsson; Björn Johansson; Bertil B. Fredholm
Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801.
Brain research. Molecular brain research 1996;35(1-2):183-9.
1995: Per Svenningsson; George Nomikos; Bertil B. Fredholm
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(11):7612-24.
1995: Per Svenningsson; A Ström; Björn Johansson; Bertil B. Fredholm
Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(5 Pt 1):3583-93.
1995: Per Svenningsson; Björn Johansson; Bertil B. Fredholm
Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum.
Acta physiologica Scandinavica 1995;154(1):17-24.